INMB
Inmune Bio, Inc.Company with tickers: INMB
Market Cap
$35.89M
Shares Outstanding
26,585,258
CIK
1711754
CUSIP
45782T105
13F Activity (30d)
3 filings
2 filers
Website
Visit website
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-23 | — | |
| 8-K | 2026-06-17 | 2026-06-16 | |
| 8-K | 2026-06-02 | — | |
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-05 | 2026-04-29 | |
| DEF 14A | 2026-04-23 | 2026-06-16 | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-02-27 | — | |
| 8-K | 2026-02-23 | — | |
| 8-K | 2026-02-19 | — | |
| 8-K | 2026-02-13 | 2026-02-10 | |
| 8-K | 2026-01-27 | — | |
| 8-K | 2025-12-23 | 2025-12-22 | |
| 8-K | 2025-12-19 | — | |
| 8-K | 2025-12-10 | 2025-12-05 | |
| 8-K | 2025-12-08 | 2025-12-05 | |
| 8-K | 2025-12-05 | 2025-12-01 | |
| 8-K | 2025-12-03 | 2025-12-02 | |
| 8-K | 2025-11-28 | 2025-11-26 | |
| 8-K | 2025-11-18 | — | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-10-30 | — | |
| 10-Q | 2025-10-30 | 2025-09-30 | |
| 8-K | 2025-10-28 | 2025-10-23 | |
| DEF 14A | 2025-10-14 | 2025-11-18 | |
| 8-K | 2025-10-14 | — | |
| 8-K | 2025-09-30 | 2025-09-29 | |
| 8-K | 2025-08-07 | 2025-08-04 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-07-29 | — | |
| 8-K | 2025-07-25 | 2025-07-24 | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-30 | 2025-06-27 | |
| 8-K | 2025-06-26 | — | |
| 8-K | 2025-06-10 | — | |
| 8-K | 2025-05-14 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-05-07 | — | |
| 8-K | 2025-05-05 | — | |
| DEF 14A | 2025-04-21 | 2025-05-28 | |
| 8-K | 2025-04-16 | — | |
| 8-K | 2025-04-14 | — | |
| 8-K | 2025-04-09 | 2025-04-03 | |
| 8-K | 2025-04-01 | — | |
| 8-K | 2025-03-27 | — | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2025-03-24 | — | |
| 8-K | 2025-03-04 | — |
Showing 1–50 of 270 filings